Bead-based multiplexing assay for antibody screening and detection

The detection of anti-human leukocyte antigen (HLA) antibodies, particularly those directed at the HLAs of the donor, has been at the forefront of donor-recipient histocompatibility testing since transplantation became a clinical reality.

As a leader in HLA antibody testing, we offer an extensive portfolio of assays for the screening and detection of antibodies, pre and post-transplant. The Thermo Scientific LABScreen product line is powered by Luminex xMAP technology—a microbead platform used to deliver multiplex assays. This allows for the precise determination of antibody profiles against HLA.

LABScreen assays produce trusted results, with consistency and high sensitivity, and are widely used in transplantation for HLA antibody detection. 

Which LABScreen product is right for your lab?


Features

Powered by Luminex xMAP technology; a multiplex assay composed of antigens bound to color-coded microbeads, detected by fluorescent emissions from R-Phycoerythrin (PE) conjugated goat antihuman IgG.

LABScreen assays

The LABScreen assays determine the presence of HLA antigens, with the capability to define percent PRA and identify antibodies against HLA Class I and Class II antigens, MICA and HNA.

Related products

Ancillary products utilized with the LABScreen portfolio, optimizing testing and analysis.

 


Not all products are CE marked or have 510(k) clearance for sale in the U.S. Availability of products in each country depends on local regulatory marketing authorization status.